Ashford Capital Management’s Pfizer PFE Stock Holding History

Ashford Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,755	Closed	-$229K	–	136
2014 Q4	$229K	Hold	7,755	–	–	0.05%	126
2014 Q3	$218K	Hold	7,755	–	–	0.05%	125
2014 Q2	$218K	Hold	7,755	–	–	0.04%	131
2014 Q1	$236K	Hold	7,755	–	–	0.05%	126
2013 Q4	$225K	Hold	7,755	–	–	0.04%	125
2013 Q3	$211K	Hold	7,755	–	–	0.04%	125
2013 Q2	$206K	Buy	+7,755	New	+$214K	0.04%	129

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ashford Capital Management's PFE Position: Q1 2015 in Review

Ashford Capital Management sold out of Pfizer (PFE) in Q1 2015, closing a stake of 7,755 shares — an estimated $229K sold.

Ashford Capital Management first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $236K in Q1 2014. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Ashford Capital Management reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
Ashford Capital Management sold 7,755 Pfizer shares in Q1 2015, an estimated $229K.
Ashford Capital Management first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
Ashford Capital Management's Pfizer position peaked at $236K in Q1 2014.
1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Ashford Capital Management's 13F filing for Q1 2015, filed 18 May 2015.